INCREASED CELL RETENTION AND EFFICACY
Tandem™ HF rapidly solves the therapeutic cell retention problem by binding cells, relieving anoikis and when delivered into the heart, anchoring cells in the damaged tissue. Furthermore, Tandem™ HF dampens down the immune system reducing cell loss due to immune rejection.
-
-
- First of its kind injectable, human heart cell-derived biomatrix
- Enables retention, distribution of therapeutic cells
- Therapeutic cells readily bind and dissociate with biomatrix
- Favorable biomatrix composition replenishes damaged heart muscle
Small-animal studies using relevant pre-clinical models have demonstrated that the properties of Tandem™ HF provide a unique advantage to the use of cell therapies alone.